104 related articles for article (PubMed ID: 38782754)
1. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
[No Abstract] [Full Text] [Related]
2. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
4. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
Gao Y; Zi D; Liang W; Qiu F; Zheng J; Xiao X; Jiang E; Xu Y
Acta Cytol; 2024; 68(2):137-144. PubMed ID: 38527422
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
7. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
8. Methylated
Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
[TBL] [Abstract][Full Text] [Related]
9. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
10. High
Li X; He S; Zhao X; Sun D; Wu S; Xu D; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1820-1829. PubMed ID: 38448375
[TBL] [Abstract][Full Text] [Related]
11. Utilization of
Yang L; Tao H; Lin B; He X; Chen Y; Fan X
Future Oncol; 2023 Sep; 19(28):1917-1927. PubMed ID: 37288536
[No Abstract] [Full Text] [Related]
12. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation for cervical cancer screening: a training set in China.
Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
[TBL] [Abstract][Full Text] [Related]
14. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
15. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
[TBL] [Abstract][Full Text] [Related]
16. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
[TBL] [Abstract][Full Text] [Related]
17. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
Wang ZM
Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
[TBL] [Abstract][Full Text] [Related]
18. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
[TBL] [Abstract][Full Text] [Related]
19. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
[TBL] [Abstract][Full Text] [Related]
20. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
